Helix BioPharma Corp.

Helix BioPharma Corp.verified

HBPCF

Price:

$1.73

Market Cap:

$178.72M

Helix BioPharma Corp. operates as an immune-oncology company in Canada. The company is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. It has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

Industry

Biotechnology

IPO Date

2009-11-27

Stock Exchange

OTC

Ticker

HBPCF

The PE Ratio as of December 2025 (TTM) for Helix BioPharma Corp. (HBPCF) is -28.83

According to Helix BioPharma Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -28.83. This represents a change of 1.47% compared to the average of -1.84 of the last 4 quarters.

Helix BioPharma Corp. (HBPCF) Historical PE Ratio (quarterly & annually)

How has HBPCF PE Ratio performed in the past?

The mean historical PE Ratio of Helix BioPharma Corp. over the last ten years is -9.74. The current -28.83 PE Ratio has changed 29.50% with respect to the historical average. Over the past ten years (40 quarters), HBPCF's PE Ratio was at its highest in in the October 2024 quarter at -1.50. The PE Ratio was at its lowest in in the October 2020 quarter at -47.08.

Quarterly (TTM)
Annual

Average

-9.74

Median

-8.01

Minimum

-18.07

Maximum

-4.67

Helix BioPharma Corp. (HBPCF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Helix BioPharma Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 89.00%

Maximum Annual PE Ratio = -4.67

Minimum Annual Increase = -67.71%

Minimum Annual PE Ratio = -18.07

Quarterly (TTM)
Annual
YearPE RatioChange
2024-5.52-14.40%
2023-6.4538.10%
2022-4.67-67.71%
2021-14.4789.00%
2020-7.65-3.53%
2019-7.93-1.84%
2018-8.08-1.45%
2017-8.20-49.83%
2016-16.35-9.53%
2015-18.0714.21%

Helix BioPharma Corp. (HBPCF) Average PE Ratio

How has HBPCF PE Ratio performed in the past?

The current PE Ratio of Helix BioPharma Corp. (HBPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-5.55

5-year avg

-7.75

10-year avg

-9.74

Helix BioPharma Corp. (HBPCF) PE Ratio vs. Peers

How is HBPCF’s PE Ratio compared to its peers?

Helix BioPharma Corp.’s PE Ratio is less than Relief Therapeutics Holding AG (-2.06), less than Calliditas Therapeutics AB (publ) (-23.95), less than PsyBio Therapeutics Corp. (-0.00), less than Relief Therapeutics Holding AG (-2.06), greater than Arch Biopartners Inc. (-34.90), less than Amplia Therapeutics Limited (-6.86), less than ZIVO Bioscience, Inc. (-4.50), less than TransCanna Holdings Inc. (-0.04), less than Oncotelic Therapeutics, Inc. (-23.15), greater than Vicapsys Life Sciences, Inc. (-62.85),

Build a custom stock screener for Helix BioPharma Corp. (HBPCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Helix BioPharma Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Helix BioPharma Corp. (HBPCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Helix BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Helix BioPharma Corp.'s PE Ratio?

How is the PE Ratio calculated for Helix BioPharma Corp. (HBPCF)?

What is the highest PE Ratio for Helix BioPharma Corp. (HBPCF)?

What is the 3-year average PE Ratio for Helix BioPharma Corp. (HBPCF)?

What is the 5-year average PE Ratio for Helix BioPharma Corp. (HBPCF)?

How does the current PE Ratio for Helix BioPharma Corp. (HBPCF) compare to its historical average?